Detail page

Knowledge Web

Person

Christian Schem (1974-)

Arzt

Name	Christian Schem
Time	1974- (Date of birth and death)
Place	Kiel (Wirkungsort) Münster (Westf) (Wirkungsort) Deutschland
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Gynäkologe
Related	Klinik für Gynäkologie und Geburtshilfe (Frauenheilkunde)
Further information	Dissertation Medizinische Fakultät Universität Münster (2000); Habilitationsschrift Medizinische Fakultät (Klinik für Gynäkologie und Geburtshilfe) an der Universität Kiel (2010)
Record type	Person
GND-Identifier	124076661
Record ID	124076661
Involved in show all Molekulare Diagnostik beim Mammakarzinom Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer Copy Number Variation (CNV) des Epidermalen Wachstumsfaktorrezeptors (EGFR) und das Metastasierungsverhalten von Brustkrebszellen im Mausmodell Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer Etablierung eines Modells intraossärer Inokulation von osteotropen MDA-MB-231-Mammakarzinomzellen im Xenograft-Mausmodell zur Untersuchung des Tumorwachstums in Abhängigkeit der Expression von TRAIL-Rezeptor 2 TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials Clinical relevance of collagen protein degradation markers c3m and c4m in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer Molekulargenetische Untersuchungen zur Diagnostik und Therapie des Mammakarzinoms Vorhersage der Ovulation durch Urin-Hormonanalysen mit dem ClearPlan Fertility Monitor : Vergleich mit transvaginalem Ultraschall und Serumhormonbestimmungen

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Christian Schem (1974-)

Molekulare Diagnostik beim Mammakarzinom

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Copy Number Variation (CNV) des Epidermalen Wachstumsfaktorrezeptors (EGFR) und das Metastasierungsverhalten von Brustkrebszellen im Mausmodell

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Etablierung eines Modells intraossärer Inokulation von osteotropen MDA-MB-231-Mammakarzinomzellen im Xenograft-Mausmodell zur Untersuchung des Tumorwachstums in Abhängigkeit der Expression von TRAIL-Rezeptor 2

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials

Clinical relevance of collagen protein degradation markers c3m and c4m in the serum of breast cancer patients treated with neoadjuvant therapy in the geparquinto trial

Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

Post-mastectomy radiotherapy after neoadjuvant chemotherapy in breast cancer: a pooled retrospective analysis of three prospective randomized trials

Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer

Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer

Molekulargenetische Untersuchungen zur Diagnostik und Therapie des Mammakarzinoms

Vorhersage der Ovulation durch Urin-Hormonanalysen mit dem ClearPlan Fertility Monitor : Vergleich mit transvaginalem Ultraschall und Serumhormonbestimmungen